← Back
$WGS All transactions

GeneDx Holdings Corp.

M

$ Value

$0

Shares

18,750

Price

$0

Filed

Sep 18

Insider

Name

Stueland Katherine

Title

CHIEF EXECUTIVE OFFICER

CIK

0001689575

Roles

Director Officer

Transaction Details

Transaction Date

2025-09-16

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

112,500

Footnotes

Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. | The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. | The price reported is a weighted average price. These shares were sold as part of a block trade for multiple security holders of the Issuer in multiple transactions at prices ranging from $118.28 to $123.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 3 with regard to the block trade. | Following the reported sales, in addition to the 14,578 shares of Class A common stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned restricted stock units ("RSUs") representing contingent rights to receive up to an aggregate of 444,539 shares of Class A common stock and options to purchase up to an aggregate of 107,610 shares of Class A common stock, which RSUs and options vest according to their respective terms. | 6.25% vest in quarterly installments over the 4-year period commencing on March 16, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.

Filing Info

Accession No.

0001689575-25-000003

Form Type

4

Issuer CIK

0001818331

Stueland Katherine's History

Date Ticker Type Value
2026-03-26 WGS M $0
2026-03-26 WGS $811K
2026-03-26 WGS $319K
2026-03-26 WGS $849K
2026-03-26 WGS $342K
2026-03-26 WGS $645K
2026-03-26 WGS M $0
2026-01-29 WGS M $0
2026-01-29 WGS $155K
2026-01-29 WGS M $0

Other Insiders at WGS (90d)

Insider Bought Sold Last
Stueland Katherine
CHIEF EXECUTIVE OFFICER
$3.1M 2026-03-26
Feeley Kevin
CHIEF FINANCIAL OFFICER
$609K 2026-03-26
Dechairo Bryan
Chief Operating Officer
$851K 2026-02-04